Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from MEDIROM Healthcare Technologies ( (MRM) ).
On September 25, 2025, MEDIROM Healthcare Technologies announced its collaboration with ‘World’, co-founded by Sam Altman and Alex Blania, to expand the installation of the World ID proof of human authentication device, Orb, across 200 of its Re.Ra.Ku relaxation studios in Japan. This move represents the largest deployment of Orbs in Japan, aiming to enhance social infrastructure by enabling individuals to prove their unique humanness, reflecting MEDIROM’s commitment to integrating healthcare and technology.
The most recent analyst rating on (MRM) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on MEDIROM Healthcare Technologies stock, see the MRM Stock Forecast page.
Spark’s Take on MRM Stock
According to Spark, TipRanks’ AI Analyst, MRM is a Neutral.
The overall stock score reflects strong revenue growth but is weighed down by profitability and liquidity challenges. The technical analysis indicates bearish momentum, while the valuation suggests potential undervaluation. The absence of earnings call and corporate events data limits further insights.
To see Spark’s full report on MRM stock, click here.
More about MEDIROM Healthcare Technologies
MEDIROM Healthcare Technologies Inc., headquartered in Minato-ku, Tokyo, is a diversified healthcare company operating over 300 wellness salons under the ‘Re.Ra.Ku®’ brand across Japan. The company has expanded into HealthTech since 2015, offering on-demand training apps and lifestyle improvement programs, and manufactures the battery-free smart tracker ‘MOTHER Bracelet®’.
Average Trading Volume: 2,704,670
Technical Sentiment Signal: Sell
Current Market Cap: $12.33M
See more insights into MRM stock on TipRanks’ Stock Analysis page.